Myasthenia Gravis Clinical Trials Myasthenia Gravis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)
Conditions:   Generalized Myasthenia Gravis;   gMG Intervention:   Drug: Ravulizumab Sponsor:   Alexion Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials